Nolpacid (Pantoprazole)

Pantoprazole, the active ingredient in Nolpacid, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid secretion and is used to treat acid‑related conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease. GNH USA supplies Nolpacid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole acts on the gastric proton pump to lower acid production, making it useful for several acid‑related gastrointestinal disorders. - Gastro‑oesophageal reflux disease (GERD): relieves heartburn and regurgitation by decreasing esophageal acid exposure. - Erosive esophagitis: promotes healing of acid‑induced esophageal lesions. - Peptic ulcer disease: supports ulcer healing and prevents recurrence. - Helicobacter pylori eradication regimens: enhances the effectiveness of antibiotic combinations. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion in this rare endocrine disorder.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually transient. - Nausea: occasional and self‑limiting. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): requires immediate medical attention. - Clostridioides difficile infection: may cause severe colitis. - Hypomagnesemia: low magnesium levels with prolonged use. - Elevated liver enzymes: indicates possible hepatic effect. - Stevens‑Johnson syndrome: rare but serious skin reaction. - Acute pancreatitis: rare inflammation of the pancreas.

Before initiating therapy, consider the following safety measures. - Assess renal function: adjust use in severe renal impairment. - Monitor magnesium levels: prolonged treatment may lead to hypomagnesemia. - Evaluate hepatic status: use with caution in patients with liver disease. - Review concomitant medications: avoid known contraindicated drugs. - Store at ambient temperature: keep in the original pack, protect from moisture.

Pantoprazole may alter the pharmacokinetics of several drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption and efficacy. - Methotrexate: increased toxicity risk.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR. - Digoxin: potential rise in serum concentration. - Diazepam: may elevate plasma levels.